SEC Form 3 · accession 0001209191-18-063530
SELLAS Life Sciences Group, Inc. · SLS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Thomas Burns
Officer — VP, Finance & Corp Controller
Period of report
Dec 17, 2018
Accepted (ET)
Dec 19, 2018 · 5:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001390478
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 18 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1,332.00 | holding | — | — | — | — | Jun 28, 2023 | Common Stock | 33 | — | D |
| Stock Option (Right to Buy)F1 | $2,328.00 | holding | — | — | — | — | Nov 26, 2023 | Common Stock | 42 | — | D |
| Stock Option (Right to Buy)F1 | $1,050.00 | holding | — | — | — | — | Jan 15, 2025 | Common Stock | 25 | — | D |
| Stock Option (Right to Buy)F1 | $1,062.00 | holding | — | — | — | — | Jun 19, 2025 | Common Stock | 33 | — | D |
| Stock Option (Right to Buy)F1 | $900.00 | holding | — | — | — | — | Dec 18, 2025 | Common Stock | 50 | — | D |
| Stock Option (Right to Buy)F1 | $504.00 | holding | — | — | — | — | Feb 23, 2026 | Common Stock | 125 | — | D |
| Stock Option (Right to Buy)F1 | $54.30 | holding | — | — | — | — | Jan 17, 2027 | Common Stock | 500 | — | D |
| Stock Option (Right to Buy)F2 | $5.24 | holding | — | — | — | — | Mar 13, 2028 | Common Stock | 20,000 | — | D |
Explanation of responses
- F1Fully vested and immediately exercisable.
- F2One-quarter (1/4) of the option shares will vest and became exercisable one year from the March 13, 2018 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date.